Monitoring and reporting
PHI’s role in monitoring and reporting of GSPA-PHI
- Setting up reporting mechanisms for Member Sates and other stakeholders
- Providing technical assistance to Member States for collection of data
- Reporting to WHO governing bodies on the overall implementation of the strategy
One of the elements of the GSPA-PHI (element 8) states that: “Systems should be established to monitor performance and progress of this strategy. A progress report will be submitted to the Health Assembly through the Executive Board every two years. A comprehensive evaluation of the strategy will be undertaken after four years”.
Additionally, action (8.1) establishes that measuring performance and progress towards objectives contained in the GSPA should include the following activities:
- Establish systems to monitor performance and progress of the implementation of each element of the GSPA.
PHI has developed a web-based platform on innovation and access following the structure of the GSPA-PHI. This platform offers a password-protected environment where governments can store, analyse and share information on their national innovation system, mapped using the assessment tool provided below.
An example of a published assessment is the one conducted in Sri Lanka, full report available below.
Meeting of Stakeholders for the “Development of a single dose malaria cure of artemether-lumefantrine through a nano-based drug delivery system"
- Survey: Global Strategy on Public Health, Innovation and Intellectual Property
Open-ended Meeting of WHO Member States
- Request for Proposals: Clinical Research Organization (CRO) to support Influenza Vaccine Clinical Trials in Serbia
Submission of an assessment report on the feasibility for establishing a pharmaceutical market data monitoring system in Ethiopia
WHO promotes, values and encourages health innovation
- Launch of Ethiopia’s National Strategy and Plan of Action for Pharmaceutical Manufacturing
- WHO publishes analysis of patent situation of new hepatitis treatments
- Follow-up of the report of the Consultative Expert Working Group on Research and Development:
ContactsPublic health, innovation, intellectual property and trade